MB
Publications
62
Views
31,013
Downloads
15,887
Supervised works
1
1 - 62 of 62
Title Published in Access level OA Policy Year Views Downloads
Impact des médicaments de la douleur sur le psychisme et la vie émotionnelle : une réflexion pour guider la prescriptionDouleur et analgésie
accessLevelRestricted
2025 1 0
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed reviewFrontiers in psychiatry
accessLevelPublic
2025 30 322
Prise en charge de la douleur aiguë en ambulatoireRevue médicale suisse
accessLevelRestricted
2024 78 0
50 ans de l’IASP : une revue de la vitalité des recherches sur la douleur et des contributions francophonesDouleur et analgésie
accessLevelRestricted
2024 2 0
Alliance thérapeutique et thérapie cognitivo-comportementale de groupeRevue médicale suisse
accessLevelPublic
2023 109 319
De nouvelles perspectives pour Douleur et AnalgésieDouleur et analgésie
accessLevelRestricted
2023 1 0
Thérapie cognitive-comportementale de groupe : quelques éléments cliniques autour des concepts de honte et de culpabilité chez les patients souffrant de douleurs chroniquesDouleur et analgésie
accessLevelRestricted
2023 4 0
Quand la discontinuation des psychotropes s’impose : manifestations cliniques et approche thérapeutiqueRevue médicale suisse
accessLevelPublic
2022 245 207
Hydromorphone Prescription for Pain in Children - What Place in Clinical Practice?Frontiers in pediatrics
accessLevelPublic
2022 186 185
Douleur et troubles du sommeilDouleur et analgésie
accessLevelRestricted
2022 2 0
À propos de l’utilisation du traitement de la kétamine aux urgences psychiatriquesRevue médicale suisse
accessLevelPublic
2021 436 545
Activité, décentration et restructuration cognitive dans la thérapie cognitivocomportementale. Éléments pour la pratique cliniqueRevue médicale suisse
accessLevelPublic
2021 396 1,388
Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separatelyBMC psychiatry
accessLevelPublic
2021 485 231
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical SettingFrontiers in pharmacology
accessLevelPublic
2021 283 324
Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in SwitzerlandFrontiers in Psychiatry
accessLevelPublic
2021 319 496
Gabapentinoids: The rise of a new misuse epidemics?Psychiatry research
accessLevelPublic
2021 240 481
Cannabinoids and COVID-19Medical Cannabis and Cannabinoids
accessLevelPublic
2020 257 203
Mise au point sur la prise en charge de la douleur chez les patients adultes atteints de déficience intellectuelleDouleur et analgésie
accessLevelRestricted
2020 63 2
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersEuropean Journal of Pain
accessLevelRestricted
2020 259 1
Opioïdes chez les patients âgés: Faux-amis ?La gazette médicale - info@gériatrie
accessLevelRestricted
2020 252 1
Crise suicidaire et prévention du suicide : aspects psychopharmacologiquesRevue médicale suisse
accessLevelPublic
2020 619 653
Antidépresseurs dans la douleur chronique : pourquoi les utiliser, comment les prescrire en pratique ?Revue médicale suisse
accessLevelRestricted
2020 503 3
Pain interventions in adults with intellectual disability: A scoping review and pharmacological considerationsEuropean Journal of Pain
accessLevelRestricted
2020 290 1
TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilitiesBMJ Open
accessLevelPublic
2020 382 153
Gestion médicamenteuse des troubles du comportement de la personne en situation de handicap mentalRevue médicale suisse
accessLevelPublic
2020 399 364
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyJournal of Personalized Medicine
accessLevelPublic
2020 358 110
A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorderBMC Psychiatry
accessLevelPublic
2019 522 1,442
Psychotropes et perturbation des tests hépatiques : conduite à tenirRevue médicale suisse
accessLevelRestricted
2018 444 2
Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory SettingJournal of Clinical Psychiatry
accessLevelRestricted
2018 492 0
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)BMC Pharmacology & Toxicology
accessLevelPublic
2017 521 223
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyPharmacological research
accessLevelPublic
2017 664 189
PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patientsBMJ Open
accessLevelPublic
2017 775 509
Le coût, ce n'est pas tout…à propos des médicaments génériquesRevue médicale suisse
accessLevelRestricted
2016 452 3
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaNeuropharmacology
accessLevelPublic
2016 594 324
Topiramate-induced severe heatstroke in an adult patient: a case reportJournal of medical case reports
accessLevelPublic
2016 520 291
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCurrent drug metabolism
accessLevelRestricted
2015 588 3
Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss CohortPloS one
accessLevelPublic
2015 602 307
Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further ImprovementsClinical therapeutics
accessLevelRestricted
2015 720 6
Douleur et sensibilisation centrale : implication des voies GABAergiques et intérêt de leur modulation
accessLevelRestricted
2015 2,083 19
Baclofen-Associated Onset of Central Sleep Apnea in Alcohol Use Disorder: A Case ReportRespiration
accessLevelRestricted
2015 645 0
Prescription d'antidépresseurs dans le traitement de la douleur : rôle de la pharmacogénétiqueRevue médicale suisse
accessLevelRestricted
2015 566 1
Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness AnalysisPloS one
accessLevelPublic
2015 525 351
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteersPain
accessLevelRestricted
2015 627 3
Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in FibromyalgiaThe journal of pain
accessLevelRestricted
2014 733 2
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic StudyBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 647 436
Reversible ventricular arrythmia induced by dasatinibClinical case reports
accessLevelPublic
2013 658 243
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialPain physician
accessLevelPublic
2013 629 1,142
Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled studyPloS one
accessLevelPublic
2013 662 474
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteersChimia
accessLevelPublic
2012 808 1,171
Analgesics in patients with hepatic impairment: pharmacology and clinical implicationsDrugs
accessLevelRestricted
2012 707 3
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combinationBasic & clinical pharmacology & toxicology
accessLevelRestricted
2011 680 0
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic painNeuropharmacology
accessLevelPublic
2011 819 695
Naloxone-responsive acute dystonia and parkinsonism following general anaesthesiaAnaesthesia
accessLevelRestricted
2009 664 0
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic studyJournal of chromatography
accessLevelRestricted
2009 564 0
Homotopic stimulation can reduce the area of allodynia in patients with neuropathic painEuropean journal of pain
2009 649 0
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteersDrug metabolism letters
2008 862 0
New approaches to the pharmacotherapy of neuropathic painExpert review of clinical pharmacology
2008 588 0
Analgésie et insuffisance rénaleRevue médicale suisse
accessLevelPublic
2008 710 560
La prescription « off-label »Revue médicale suisse
accessLevelRestricted
2008 699 0
Prise en charge médicamenteuse de la douleur neuropathique : quelle place pour les traitements topiques?Revue médicale suisse
accessLevelRestricted
2008 429 0
Automédication chez les sans-papiers latino-américains : entre le nécessaire et l'inappropriéRevue médicale suisse
2007 423 0
Genre et douleur : influence du cycle menstruel sur le seuil expérimental d'apparition de la douleur
accessLevelPublic
2004 1,543 1,499
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack